###begin article-title 0
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 79 86 <span type="species:ncbi:9606">patient</span>
A novel de novo mutation in the serine-threonine kinase STK11 gene in a Korean patient with Peutz-Jeghers syndrome
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 167 175 <span type="species:ncbi:9606">Patients</span>
Peutz-Jeghers syndrome (PJS) is an unusual autosomal dominant disorder characterized by mucocutaneous pigmentation and multiple gastrointestinal hamartomatous polyps. Patients with PJS are at an increased risk of developing multi-organ cancer, most frequently those involving the gastrointestinal tract. Germline mutation of the STK11 gene, which encodes a serine-threonine kinase, is responsible for PJS.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 36 43 <span type="species:ncbi:9606">patient</span>
Using DNA samples obtained from the patient and his family members, we sequenced nine exons and flanking intron regions of the STK11 gene using polymerase chain reaction (PCR) and direct sequencing.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 410 418 410 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 365 372 <span type="species:ncbi:9606">patient</span>
Sequencing of the STK11 gene in the proband of the family revealed a novel 1-base pair deletion of guanine (G) in exon 6 (c.826delG; Gly276AlafsX11). This mutation resulted in a premature termination at codon 286, predicting a partial loss of the kinase domain and complete loss of the C-terminal domain. We did not observe this mutation in both parents of the PJS patient. Therefore, it is considered a novel de novo mutation.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 130 137 <span type="species:ncbi:9606">patient</span>
The results presented herein enlarge the spectrum of mutations of the STK11 gene by identifying a novel de novo mutation in a PJS patient and further support the hypothesis that STK11 mutations are disease-causing mutations for PJS with or without a positive family history.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 258 266 <span type="species:ncbi:9606">Patients</span>
Peutz-Jeghers syndrome (PJS; OMIM 175200) is a rare, autosomal dominant disorder characterized by melanocytic macules of the lips, buccal mucosa, and digits, along with multiple gastrointestinal hamartomatous polyps, frequently in the small intestine [1,2]. Patients with PJS are at an increased risk of developing gastrointestinal cancer and extraintestinal neoplasms involving organs such as the ovaries, testes, breasts, pancreas, lungs, or uterine cervix [3].
###end p 11
###begin p 12
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKb1 </italic>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 348 354 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XEEK1 </italic>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 393 416 393 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans </italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">par-4</italic>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 463 479 463 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">drosophila Lkb1 </italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 355 362 <span type="species:ncbi:8355">Xenopus</span>
###xml 393 415 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Currently, only mutations in the gene STK11 (also known as LKB1; OMIM 602216) at chromosome 19p13.3 have been identified as a cause of PJS [4,5]. The human STK11 gene encodes a 433 amino acid serine-threonine kinase. STK11 is known to be located both in the nucleus and the cytoplasm of all human tissues [6], and orthologs include mouse LKb1 [7], XEEK1 (Xenopus egg and embryo kinase 1) [8], Caenorhabditis elegans partitioning defective gene 4 (par-4) [9], and drosophila Lkb1 [10].
###end p 12
###begin p 13
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 469 471 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 484 486 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 565 567 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Loss of the normal allele has been observed in polyps from patients with PJS, and loss of heterozygosity (LOH) has been noted to occur in some tumor tissues, suggesting that STK11 is a tumor suppressor gene [11]. STK11 has been shown to cause apoptosis in intestinal epithelial cells, and is physically associated with p53, regulating specific p53-dependent apoptosis pathways [12]. STK11 is also known to have effects on G1 cell cycle arrest [13], TGF-beta signaling [14], polarity [15], and phosphorylating and activating the AMP-activated protein kinase (AMPK) [16].
###end p 13
###begin p 14
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 292 297 <span type="species:ncbi:9606">Human</span>
Screening for point mutations and large deletions by direct sequencing or by multiplex ligation-dependent probe amplification (MLPA) increased the mutation detection rate in the STK11 gene up to 94% [17]. To date, more than 200 different mutations in the STK11 gene have been reported at the Human Gene Mutation Database (HGMD) website  and most are small insertions/deletions or missense/nonsense mutations.
###end p 14
###begin p 15
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 265 273 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 26 33 <span type="species:ncbi:9606">patient</span>
###xml 242 249 <span type="species:ncbi:9606">patient</span>
We report on a Korean PJS patient with a novel STK11 mutation. During molecular genetic testing for STK11 mutation, we detected a novel small deletion in exon 6, causing a premature stop codon. This mutation was absent in both parents of the patient and was thus a de novo mutation.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Subjects
###end title 17
###begin p 18
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 372 379 <span type="species:ncbi:9606">patient</span>
###xml 408 415 <span type="species:ncbi:9606">patient</span>
###xml 502 509 <span type="species:ncbi:9606">patient</span>
The proband was a 13-year-old Korean male. He was diagnosed clinically with PJS at six years of age based on the presence of characteristic mucocutaneous pigmentation of the lips and buccal mucosa, and gastrointestinal hamartomatous polyps after polypectomy (Figure 1). After obtaining informed consent, blood samples were collected from four family members including the patient. Brother and parents of the patient did not consent to endoscopic examinations for evaluation of polyps. Relatives of the patient had no known medical conditions, including mucocutaneous pigmentation or malignancies, and no further study was assessed (Figure 2).
###end p 18
###begin p 19
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pathologic findings of the Peutz-Jeghers polyp</bold>
Pathologic findings of the Peutz-Jeghers polyp. The colonic polyp shows hyperplastic mucosal epithelium and arborizing pattern of smooth muscle, consistent with a hamartomatous polyp (Hematoxylin-eosin stain, 200x).
###end p 19
###begin p 20
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pedigree of the family with PJS</bold>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circle</italic>
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">square</italic>
###xml 63 75 63 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black symbol</italic>
Pedigree of the family with PJS. Circle, female; square, male; black symbol, affected. Asterisk (*) indicates the family member who was available for genetic analysis.
###end p 20
###begin title 21
Mutation studies
###end title 21
###begin p 22
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 629 635 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 34 41 <span type="species:ncbi:9606">patient</span>
Four family members including the patient were included in this study after obtaining informed consent. The genomic DNA was isolated from peripheral blood leukocytes using the Wizard Genomic DNA Purification Kit according to the manufacturer's instructions (Promega, Madison, WI, USA). The polyp tissue was not collected for DNA analysis. The STK11 gene was amplified via PCR [by using the appropriate primers as designed by the authors (available upon request)] and a thermal cycler (Model 9700; Applied Biosystems, Foster City, CA, USA). Direct sequencing of all nine coding exons along with the flanking intron regions of the STK11 gene was performed with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) in conjunction with an ABI Prism 3100 automated genetic analyzer (Applied Biosystems).
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Direct sequencing analysis of the proband demonstrated a heterozygous 1-bp deletion of guanine (G) (c.826delG; Gly276AlafsX11) in exon 6 of the STK11 gene, which resulted in a frameshift leading to premature termination of the 433 amino acid protein at the 286th codon, disruption of the kinase domain, and complete loss of carboxyterminal non-catalytic region. This mutation was absent in his family members and 100 control chromosomes (Figure 3).
###end p 24
###begin p 25
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the STK11 gene mutation</bold>
###xml 134 140 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
Identification of the STK11 gene mutation. Direct sequencing of the proband demonstrated a 1-bp deletion (c.826delG) in exon 6 of the STK11 gene, resulting in a frameshift deletion mutation (p.Gly276AlafsX11). The proband's family members did not have the mutation. The localization of the deletion is indicated by the arrow.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 803 809 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 284 289 <span type="species:ncbi:9606">Human</span>
Germline mutations in the STK11 gene on chromosome 19p13.3 have been shown to be the cause of PJS [4,5]. Recent study suggests that the STK11 mutation detection rate was above 90% [17]. However, some families with PJS have shown linkage to chromosomal region 19q13.4 [18] and 6 [19]. Human STK11 consists of nine coding exons with a 433 amino acid coding sequence, and one non-coding exon 10 that spans 23 kb [6,7]. The STK11 protein is mainly comprised of three major domains: the N-terminal non-catalytic domain containing the nuclear localization signal, the catalytic kinase domain important for ATP binding, and the carboxyterminal non-catalytic regulatory domain containing prenylation motif (CAAX-box). Codons 49-309 encode the catalytic kinase domain. The C-terminal non-catalytic region of the STK11 protein is encoded by exon 8 and 9 and encompasses amino acids 309-433.
###end p 27
###begin p 28
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN </italic>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 812 818 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 903 911 903 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 289 296 <span type="species:ncbi:9606">patient</span>
###xml 536 543 <span type="species:ncbi:9606">patient</span>
The patient recruited in this study fulfilled the well-established clinical diagnostic criteria for PJS [20]. The criteria include histopathologically proven hamartomas together with classical mucocutaneous hyperpigmentation and small-bowel polyposis. Therefore, the possibility that this patient is affected with hamartomatous polyposis syndromes other than PJS is highly unlikely. Such syndromes include juvenile polyposis syndrome, PTEN hamartoma tumor syndrome, and Carney complex. In our study, we sequenced the STK11 gene in this patient with PJS. We identified a novel heterozygous 1-bp deletion (c.826delG; Gly276AlafsX11) in exon 6 of the STK11 gene, which resulted in a frameshift leading to premature termination of the 433 amino acid protein at the 286th codon. This mutation was not detected in the STK11 sequencing analysis of his family members, indicating that Gly276AlafsX11 is a novel de novo mutation.
###end p 28
###begin p 29
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 590 596 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 627 633 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11</italic>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
The Gly276AlafsX11 mutation is located in the catalytic kinase domain of STK11 protein, so we hypothesize that this mutation may lead to partial loss of the kinase domain and complete loss of the C-terminal domain. This mutation is novel, but a similar effect of the mutation in the STK11 protein was reported recently [21]. Loss of STK11 protein kinase activity associated with loss of growth suppression function was reported in some mutations in STK11 associated with PJS [4,22]. Thus, development of the PJS phenotypes is believed to be due to the elimination of the kinase activity of STK11 [23]. The C-terminal domain of STK11 is important for the control of both the AMPK pathway and cell polarity [15]. Mutations leading to loss of the C-terminal domain of STK11, as observed in this case, lead to loss of cell polarity, resulting in the development of malignancies. Taken together, these data suggest that the STK11 mutation in exon 6 may contribute to polyp formation and tumorgenesis through various mechanisms such as loss of growth arrest, apoptosis, and loss of cell polarity. Further studies will be needed to address these questions.
###end p 29
###begin p 30
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
Although an increased cancer risk in patients with PJS is well established [3,24], data on genotype-phenotype correlation is lacking. Schumacher et al. studied 146 PJS patients and determined that inframe deletions, splice site mutations, and missense mutations in the catalytic kinase domain were rarely associated with cancer. However, it was felt that missense mutations in the C-terminal domain were more frequently associated with malignancies [22]. Recently, however, Hearle et al. studied 419 PJS patients and determined that the type or site of the STK11 mutation did not significantly influence cancer risk [25]. Restricted by the few published papers on this topic, the genotype-phenotype correlation remains to be further investigated.
###end p 30
###begin title 31
Conclusion
###end title 31
###begin p 32
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK11 </italic>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 287 295 <span type="species:ncbi:9606">patients</span>
We enlarged the spectrum of mutations of the STK11 gene by identifying a novel mutation in a Korean patient with PJS. Because of the increased risk of PJS in patients with multi-organ cancers, molecular diagnosis will be an important factor in genetic counseling, clinical management of patients, and tumor screening.
###end p 32
###begin title 33
List of abbreviations
###end title 33
###begin p 34
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 76 83 <span type="species:ncbi:8355">Xenopus</span>
PJS: Peutz-Jeghers syndrome; STK11/LKB1: serine-threonine kinase 11; XEEK1: Xenopus egg and embryo kinase 1; LOH: loss of heterozygosity; AMPK: AMP activated protein kinase; MLPA: multiplex ligation-dependent probe amplification.
###end p 34
###begin title 35
Competing interests
###end title 35
###begin p 36
The authors declare that they have no competing interests.
###end p 36
###begin title 37
Authors' contributions
###end title 37
###begin p 38
###xml 198 205 <span type="species:ncbi:9606">patient</span>
JY recruited all the subjects investigated, carried out the molecular genetic studies, and drafted the manuscript. Y-KS, K-AL, and C-SK helped with the experiments. JY, Y-JC, and J-GK diagnosed the patient and participated in the editing of the manuscript. J-RC designed and supervised the study. All authors read and approved the final manuscript.
###end p 38
###begin title 39
Pre-publication history
###end title 39
###begin p 40
The pre-publication history for this paper can be accessed here:
###end p 40
###begin p 41

###end p 41
###begin title 42
Acknowledgements
###end title 42
###begin p 43
###xml 24 31 <span type="species:ncbi:9606">patient</span>
###xml 148 155 <span type="species:ncbi:9606">patient</span>
We gratefully thank the patient and his family members for their cooperation in the research. Written consent for publication was obtained from the patient and his family members. This work was supported by the National Health Insurance Corporation Ilsan Hospital grant (2007-59).
###end p 43
###begin article-title 44
Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance
###end article-title 44
###begin article-title 45
On a very remarkable case of familial polyposis of the mucous membrane of the intestinal tract and nasopharynx accompanied by peculiar pigmentation of the skin and mucous memebrane
###end article-title 45
###begin article-title 46
Very high risk of cancer in familial Peutz-Jeghers syndrome
###end article-title 46
###begin article-title 47
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
###end article-title 47
###begin article-title 48
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
###end article-title 48
###begin article-title 49
LKB1-a master tumour suppressor of the small intestine and beyond
###end article-title 49
###begin article-title 50
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase
###end article-title 50
###begin article-title 51
###xml 91 98 <span type="species:ncbi:8355">Xenopus</span>
Cloning and characterization of a novel serine/threonine protein kinase expressed in early Xenopus embryos
###end article-title 51
###begin article-title 52
###xml 4 14 <span type="species:ncbi:6239">C. elegans</span>
The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry
###end article-title 52
###begin article-title 53
###xml 11 21 <span type="species:ncbi:7227">Drosophila</span>
A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity
###end article-title 53
###begin article-title 54
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
###end article-title 54
###begin article-title 55
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death
###end article-title 55
###begin article-title 56
Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest
###end article-title 56
###begin article-title 57
LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1
###end article-title 57
###begin article-title 58
Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity
###end article-title 58
###begin article-title 59
Analysis of the LKB1-STRAD-MO25 complex
###end article-title 59
###begin article-title 60
High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome
###end article-title 60
###begin article-title 61
Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4
###end article-title 61
###begin article-title 62
###xml 47 54 <span type="species:ncbi:9606">patient</span>
A pericentric inversion of chromosome six in a patient with Peutz-Jeghers' syndrome and the use of FISH to localise the breakpoints on a genetic map
###end article-title 62
###begin article-title 63
Increased risk of cancer in the Peutz-Jeghers syndrome
###end article-title 63
###begin article-title 64
###xml 83 91 <span type="species:ncbi:9606">patients</span>
A novel mutation in STK11 gene is associated with Peutz-Jeghers Syndrome in Indian patients
###end article-title 64
###begin article-title 65
STK11 genotyping and cancer risk in Peutz-Jeghers syndrome
###end article-title 65
###begin article-title 66
The molecular basis and clinical aspects of Peutz-Jeghers syndrome
###end article-title 66
###begin article-title 67
Cancer and the Peutz-Jeghers syndrome
###end article-title 67
###begin article-title 68
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
###end article-title 68

